2021
DOI: 10.1016/j.phclin.2020.12.004
|View full text |Cite
|
Sign up to set email alerts
|

État des lieux de l’utilisation des anti-TNF α : adalimumab et étanercept chez les patients atteints de rhumatismes inflammatoires chroniques (RIC) dans une unité de pharmacie à l’hôpital

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 12 publications
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?